Many US ICD implants not evidence based

For patients with severe systolic heart failure, several randomised trials have shown the ability of implantable cardioverter-defibrillator (ICD) devices to prevent sudden cardiac death. ¬†However, current US guidelines recommend against ICD insertion within 3 months of an initial heart-failure diagnosis, or within forty days of a myocardial infarction. […]

Read More…

Decrease in risk of community sudden cardiac death over the last 30 years

Although several large clinical trials have recently examined the risk of sudden cardiac death after myocardial infarction (MI), community-based data reflecting the contemporary risk of sudden cardiac death after MI are lacking. Adabag et al. determined to evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure […]

Read More…